Einstein-Rockefeller-CUNY Center for AIDS Research

Developmental Core

The overarching goal of the Einstein/Rockefeller/Hunter CFAR (ERC-CFAR) Developmental Core is to support the career development of early stage investigators (ESIs) through an effective mentoring process coupled with a peer-reviewed Catalytic grants program and ongoing support for their scientific growth via participation in programs specifically tailored for ESIs. The objectives of the ERC-CFAR Developmental core are centered on mentoring ESIs, catalyzing trans-institutional collaborative AIDS research in the ERC-CFAR, supporting Scientific Working Group (SWG) efforts to catalyze research in their topic areas, facilitating scientific communication among ERC-CFAR investigators and enhancing international HIV/AIDS research. Specifically the Core:

  • Provides individually tailored mentoring to ESIs and facilitates their development into independently funded researchers by pairing ESIs with established investigators (EIs), by providing both individual and group-level mentoring to help them develop NIH K- or R- type grants and by assisting senior level ESIs with transition to an R01 funding.
  • Supports ESIs engaged in AIDS research in the ERC-CFAR via catalytic and micro grants, which will also be used to promote trans- institutional collaborations and to support SWG priorities.
  • Stimulates intra- and trans-institutional, collaborative AIDS research at the participating institutions by awarding joint catalytic grants and proactively recruits non-AIDS EIs engaged in cutting edge research into AIDS research.
  • Facilitates scientific communication among ERC-CFAR investigators by organizing a bi-weekly Trans-institutional ERC-CFAR research seminar series and the biweekly Clinical AIDS Grand Rounds series both of which are simulcast to all three institutions, ERC-CFAR Invited Speaker Seminars, Annual ERC-CFAR Scientific Retreats to foster scientific interaction.
  • Promotes AIDS Research in the ERC-CFAR via integration with other Einstein programs such as WIHS, the AIDS T32 program and African HIV/AIDS research programs.
  • Facilitates and mentors ESIs in conducting community participatory and behavioral AIDS research via collaboration with the Behavioral Science Core.
  • For further information or to access the Developmental Core services, please contact Drs. Prasad or Cunningham. 

Dr. Vinayaka Prasad
Director, ERC-CFAR Developmental Core
Director, HIV/AIDS Training Grant
Professor, Microbiology & Immunology, Einstein  

Dr. Chinazo Cunningham
Co-Director, ERC-CFAR Developmental Core
Professor, Medicine and of Family & Social Medicine 
Director, Diversity Affairs for the Dept. of Medicine
Associate Chief, Division of General Internal Medicine, Einstein

 
 

Einstein Logo 

Rockefeller Logo 

CUNY Logo 

 
 

ERC-CFAR at a Glance

Partner Institutions 

  • Albert Einstein College of Medicine
  • Rockefeller University
  • The City University of New York (CUNY)
 

Investigators 

Total ERC-CFAR members

  • 183 Full members
  • 10 Affiliate members

CFAR member trainees funded by NIH K awards

  • 15 Full members
 

NIH Funding 

FY2015 OAR NIH AIDS FRB grants

$34,084,840 Total costs

 

New NIH AIDS grants awarded in FY2016

$7,345,645 Total annual costs

 

FY2014 non-AIDS NIH grants

$34,745,334 Total costs

Publications (first 6 months of 2016) 

Total Publications: 240

Publications multi-authored
by ERC-CFAR members: 91

Cores 

Administrative 

Director: Dr. H. Goldstein

 

Developmental 

Directors: Dr. V. Prasad & Dr. C. Cunningham

 

Biomarkers & Advanced Technologies 

Directors: Dr. J. Berman & Dr. S. Almo

 

Behavioral Science 

Director: Dr. L. Bauman

 

Clinical Translational Implementation Science 

Director: Dr. K. Anastos

 

Scientific Working Groups 

HIV and Eradication 

Directors: Dr. G. Kalpana & Dr. M. Caskey

 

Patient and Population Health Outcomes Research 

Directors: Dr. D. Nash & Dr. J. Arnsten  

New 2016 NIH Grants Awards 

 
Click here to log in

In the Media

Vice interviews Harris Goldstein, M.D., about the difficulty of developing a vaccine for HIV. Dr. Goldstein is professor of pediatrics and of microbiology & immunology at Einstein and director of the Einstein-Rockefeller-CUNY Center for AIDS Research. (Wednesday, Aug 30, 2017)

Crain’s Health Pulse interviews Dr. Laurie Bauman regarding a collaborative study aimed at controlling the spread of HIV using PrEP, a drug proven to reduce risk. Dr. Bauman is a principal investigator on the study, which includes Einstein, Montefiore and Columbia. She also is director of the Preventive Intervention Research Center and professor of pediatrics. (Friday, Jul 29, 2016)

media coverage on other stories